Medical Weight Loss for Spartanburg, South Carolina Residents

Spartanburg, South Carolina residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Spartanburg through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Spartanburg: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps South Carolina patients choose. Doctor review just $119 (medication separate).

Why Spartanburg Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Spartanburg it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across South Carolina tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

Medical weight loss for Spartanburg is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Spartanburg sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across South Carolina. We care for patients throughout downtown Spartanburg and the greater Spartanburg County area of the Upstate. You can have your first video visit from your kitchen in Spartanburg and have your treatment plan in motion the same week.

Most people across Spartanburg do not wait for an opening, they pick a time, meet Dr. Sharma by video, and can begin treatment within days. We accept HSA and FSA cards for the $119 physician review, which lets many Spartanburg patients use pre-tax dollars toward their care. Across fast-growing South Carolina, New Hope Weight Loss treats patients entirely by telehealth from our Costa Mesa, California clinic, with no local office and no need to travel.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Spartanburg and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Spartanburg

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Spartanburg address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Spartanburg

Where is the New Hope Weight Loss location serving Spartanburg?

The location serving Spartanburg is our Costa Mesa, California clinic, which is our only physical site. We care for Spartanburg, South Carolina patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Spartanburg patients?

It is the standard for Spartanburg. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Spartanburg in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Spartanburg patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Spartanburg patients.

What areas of Spartanburg do you serve?

We serve patients from across Spartanburg by telehealth, including downtown Spartanburg and the greater Spartanburg County area of the Upstate.

What does treatment cost for Spartanburg patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Spartanburg.

Spartanburg Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Spartanburg, South Carolina by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.